Azur Pharma Public Ltd Co - FORM 10-K/A - EX-31.3 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - April 27, 2012

Attached files

file filename
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Azur Pharma Public Ltd Cod340370d10ka.htm
EX-31.4 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Azur Pharma Public Ltd Cod340370dex314.htm
EX-10.34 - AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN - Azur Pharma Public Ltd Cod340370dex1034.htm
EX-10.33 - JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN - Azur Pharma Public Ltd Cod340370dex1033.htm

EXHIBIT 31.3

CERTIFICATION

I, Bruce C. Cozadd, certify that:

 

  1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Jazz Pharmaceuticals Public Limited Company (formerly known as Azur Pharma Public Company Limited); and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: April 27, 2012   By:  

/S/    BRUCE C. COZADD        

    Bruce C. Cozadd
    Chairman and Chief Executive Officer